Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Liver Diseases

Free Subscription 01.10.2018 2 AJR Am J Roentgenol 1 Am J Pathol 1 BMC Cancer 1 BMC Gastroenterol 2 Dig Dis Sci 4 Eur Radiol 2 Hepatology 1 Int J Cancer 1 J Comput Assist Tomogr 2 J Hepatol 1 J Pediatr 3 Lancet 1 Lancet Gastroenterol Hepatol 1 Oncogene 1 Radiology 3 Transplant Proc 1 Transplantation

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AJR Am J Roentgenol

1. SHETTY AS, Mittal A, Salter A, Narra VR, et al
   Hepatopancreaticobiliary Imaging Second-Opinion Consultations: Is There Value in the Second Reading?
   AJR Am J Roentgenol. 2018 Sep 24:1-8. doi: 10.2214/AJR.17.19452.
   PubMed     Text format     Abstract available
   
   
2. HORVAT N, Rocha MS, Chagas AL, Oliveira BC, et al
   Multimodality Screening of Hepatic Nodules in Patients With Congenital Heart Disease After Fontan Procedure: Role of Ultrasound, ARFI Elastography, CT, and MRI.
   AJR Am J Roentgenol. 2018 Sep 24:1-9. doi: 10.2214/AJR.18.19762.
   PubMed     Text format     Abstract available
   
   

   
   Am J Pathol

3. STROWITZKI MJ, Kirchberg J, Tuffs C, Schiedeck M, et al
   Loss Of Prolyl-Hydroxylase 1 Protects Against Biliary Fibrosis Via Attenuated Activation Of Hepatic Stellate Cells.
   Am J Pathol. 2018 Sep 21. pii: S0002-9440(17)30621.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

4. AN C, Kim DY, Choi JY, Han KH, et al
   Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
   BMC Cancer. 2018;18:915.
   PubMed     Text format     Abstract available
   
   

   
   BMC Gastroenterol

5. FRIEDRICH D, Marschall HU, Lammert F
   Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
   BMC Gastroenterol. 2018;18:76.
   PubMed     Text format     Abstract available
   
   

   
   Dig Dis Sci

6. YANNY B, Saab S, Durazo F, Latt N, et al
   Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naive Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mL.
   Dig Dis Sci. 2018 Sep 27. pii: 10.1007/s10620-018-5283.
   PubMed     Text format     Abstract available
   
   
7. KORNBERG A, Schernhammer M, Kornberg J, Friess H, et al
   Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma.
   Dig Dis Sci. 2018 Sep 27. pii: 10.1007/s10620-018-5296.
   PubMed     Text format     Abstract available
   
   

   
   Eur Radiol

8. CALANDRI M, Yamashita S, Gazzera C, Fonio P, et al
   Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival.
   Eur Radiol. 2018;28:2727-2734.
   PubMed     Text format     Abstract available
   
   
9. MARQUARDT S, Kirstein MM, Bruning R, Zeile M, et al
   Percutaneous hepatic perfusion (chemosaturation) with melphalan in patients with intrahepatic cholangiocarcinoma: European multicentre study on safety, short-term effects and survival.
   Eur Radiol. 2018 Sep 25. pii: 10.1007/s00330-018-5729.
   PubMed     Text format     Abstract available
   
   
10. IYAMA A, Nakaura T, Iyama Y, Kidoh M, et al
    Spiral flow-generating tube for saline chaser improves aortic enhancement in Gd-EOB-DTPA-enhanced hepatic MRI.
    Eur Radiol. 2018 Sep 25. pii: 10.1007/s00330-018-5733.
    PubMed     Text format     Abstract available
    
    
11. JOO I, Lee JM, Lee DH, Jeon JH, et al
    Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features?
    Eur Radiol. 2018 Sep 25. pii: 10.1007/s00330-018-5727.
    PubMed     Text format     Abstract available
    
    

    
    Hepatology

12. SIRICA AE, Gores GJ, Groopman JD, Selaru FM, et al
    Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances.
    Hepatology. 2018 Sep 25. doi: 10.1002/hep.30289.
    PubMed     Text format     Abstract available
    
    
13. WILKINSON PD, Delgado ER, Alencastro F, Leek MP, et al
    The polyploid state restricts hepatocyte proliferation and liver regeneration.
    Hepatology. 2018 Sep 23. doi: 10.1002/hep.30286.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

14. LEE JH
    Analysis of The Cancer Genome Atlas data to determine the correlation between PROX1 and TERT in hepatocellular carcinoma.
    Int J Cancer. 2018 Sep 24. doi: 10.1002/ijc.31888.
    PubMed     Text format    
    
    

    
    J Comput Assist Tomogr

15. STOCKER D, Bashir MR, Kannengiesser SAR, Reiner CS, et al
    Accuracy of Automated Liver Contouring, Fat Fraction, and R2* Measurement on Gradient Multiecho Magnetic Resonance Images.
    J Comput Assist Tomogr. 2018;42:697-706.
    PubMed     Text format     Abstract available
    
    

    
    J Hepatol

16. DEUGNIER Y, Morcet J, Laine F, Hamdi-Roze H, et al
    Reduced phenotypic expression in genetic hemochromatosis with time: role of exposure to nongenetic modifiers.
    J Hepatol. 2018 Sep 20. pii: S0168-8278(18)32383.
    PubMed     Text format     Abstract available
    
    
17. LOW JTS, Rohde G, Pittordou K, Candy B, et al
    Supportive and palliative care in people with cirrhosis: international systematic review of the perspective of patients, family members and health professionals.
    J Hepatol. 2018 Sep 19. pii: S0168-8278(18)32381.
    PubMed     Text format     Abstract available
    
    

    
    J Pediatr

18. IACOBAS I, Phung TL, Adams DM, Trenor CC 3rd, et al
    Guidance Document for Hepatic Hemangioma (Infantile and Congenital) Evaluation and Monitoring.
    J Pediatr. 2018 Sep 21. pii: S0022-3476(18)31122.
    PubMed     Text format     Abstract available
    
    

    
    Lancet

19. SCHACHTER J, Ribas A, Long GV, Arance A, et al
    Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006).
    Lancet. 2017 Aug 16. pii: S0140-6736(17)31601.
    PubMed     Text format     Abstract available
    
    
20. CHARLTON M
    FGF-19 agonism for NASH: a short study of a long disease.
    Lancet. 2018;391:1124-1126.
    PubMed     Text format    
    
    
21. REIG M, Bruix J
    Lenvatinib: can a non-inferiority trial change clinical practice?
    Lancet. 2018;391:1123-1124.
    PubMed     Text format    
    
    

    
    Lancet Gastroenterol Hepatol

22. ROWE IA
    Too much medicine: overdiagnosis and overtreatment of non-alcoholic fatty liver disease.
    Lancet Gastroenterol Hepatol. 2018;3:66-72.
    PubMed     Text format     Abstract available
    
    

    
    Oncogene

23. DOU C, Zhou Z, Xu Q, Liu Z, et al
    Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca(2+)/PI3K/AKT pathway.
    Oncogene. 2018 Sep 24. pii: 10.1038/s41388-018-0505.
    PubMed     Text format     Abstract available
    
    

    
    Radiology

24. CHERNYAK V, Fowler KJ, Kamaya A, Kielar AZ, et al
    Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.
    Radiology. 2018 Sep 25:181494. doi: 10.1148/radiol.2018181494.
    PubMed     Text format     Abstract available
    
    

    
    Transplant Proc

25. PAI SL, Aniskevich S 3rd, Logvinov II, Matcha GV, et al
    Hypertrophic Cardiomyopathy in Liver Transplantation Patients.
    Transplant Proc. 2018;50:1466-1469.
    PubMed     Text format     Abstract available
    
    
26. COELHO GR, Praciano AM, Viana GNR, Lima CA, et al
    Outcomes of Liver Transplant Recipients With Model for End-Stage Liver Disease Exception: Single-Center Experience in the Northeast of Brazil.
    Transplant Proc. 2018;50:1428-1430.
    PubMed     Text format     Abstract available
    
    
27. ERSHOFF BD, Gordin JS, Vorobiof G, Elashoff D, et al
    Improving the Prediction of Mortality in the High Model for End-Stage Liver Disease Score Liver Transplant Recipient: A Role for the Left Atrial Volume Index.
    Transplant Proc. 2018;50:1407-1412.
    PubMed     Text format     Abstract available
    
    

    
    Transplantation

28. LU WY, Forbes SJ
    Telomerase Activity Links to Regenerative Capacity of Hepatocytes.
    Transplantation. 2018;102:1587-1588.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: